84. Sarcoidosis Clinical trials / Disease details
Clinical trials : 149 / Drugs : 202 - (DrugBank : 78) / Drug target genes : 66 - Drug target pathways : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04320121 (ClinicalTrials.gov) | March 11, 2020 | 17/3/2020 | Effect of Nelutri™ on Musculoskeletal Biomarkers in Relative Sarcopenia Adults | Effect of Nelutri™ on Musculoskeletal Biomarkers in Relative Sarcopenia Adults: a Randomized, Double-blinded, Placebo-controlled Trial | Muscular Sarcoidosis | Dietary Supplement: Nelutri™;Dietary Supplement: Placebo group | Pusan National University Yangsan Hospital | NULL | Completed | 19 Months | N/A | All | 80 | N/A | Korea, Republic of |